No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs896545 |
chr5:101633610-101633611 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs569974071 |
chr5:101633643-101633644 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs144609197 |
chr5:101633664-101633665 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs529198058 |
chr5:101633747-101633748 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs547268123 |
chr5:101633751-101633752 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs565931054 |
chr5:101633793-101633794 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs543158119 |
chr5:101633841-101633842 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs188062469 |
chr5:101633867-101633868 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs192650213 |
chr5:101633869-101633870 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs184491235 |
chr5:101633871-101633872 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs569780504 |
chr5:101633885-101633886 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs564528522 |
chr5:101633953-101633954 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs536612628 |
chr5:101633963-101633964 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs555342494 |
chr5:101633967-101633968 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs190601470 |
chr5:101634015-101634016 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs536184793 |
chr5:101634022-101634023 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs553941368 |
chr5:101634045-101634046 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs572331362 |
chr5:101634053-101634054 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs546004420 |
chr5:101634058-101634059 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs532016658 |
chr5:101634111-101634112 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs78081330 |
chr5:101634112-101634113 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs138355209 |
chr5:101634160-101634161 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs373445110 |
chr5:101634169-101634170 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs559413039 |
chr5:101634252-101634253 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs10479191 |
chr5:101634271-101634272 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs562155778 |
chr5:101634274-101634275 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs529174498 |
chr5:101634306-101634307 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs192687626 |
chr5:101634390-101634391 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs371095740 |
chr5:101634435-101634436 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs184937754 |
chr5:101634436-101634437 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs533124651 |
chr5:101634482-101634483 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs551622362 |
chr5:101634511-101634512 |
Weak transcription Enhancers Flanking Active TSS
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs188921750 |
chr5:101634541-101634542 |
Weak transcription Enhancers Flanking Active TSS
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs57977588 |
chr5:101634545-101634546 |
Weak transcription Enhancers Flanking Active TSS
|
CpG island
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs570118146 |
chr5:101634560-101634561 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs181657155 |
chr5:101634572-101634573 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs59934563 |
chr5:101634575-101634576 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs62372171 |
chr5:101634577-101634578 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs535751670 |
chr5:101634641-101634642 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs73774617 |
chr5:101634645-101634646 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs185601307 |
chr5:101634646-101634647 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs553596687 |
chr5:101634655-101634656 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs149276384 |
chr5:101634710-101634711 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs537347579 |
chr5:101634716-101634717 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs189722176 |
chr5:101634758-101634759 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs56881277 |
chr5:101634770-101634771 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs180847575 |
chr5:101634771-101634772 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs569521575 |
chr5:101634784-101634785 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs555456036 |
chr5:101634801-101634802 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs574015315 |
chr5:101634894-101634895 |
Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|